β-blockers in advanced cirrhosis: More friend than enemy
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
Clin Mol Hepatol. 2021;27(3):425-436.   Published online 2020 Dec 3     DOI: https://doi.org/10.3350/cmh.2020.0234
Citations to this article as recorded by Crossref logo
Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clinical and Molecular Hepatology.2022; 28(1): 31.     CrossRef
Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy
Hongqun Liu, Henry H. Nguyen, Ki Tae Yoon, Samuel S. Lee
Frontiers in Network Physiology.2022;[Epub]     CrossRef
Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database
Hankil Lee, Beom Kyung Kim
Journal of Gastroenterology and Hepatology.2022; 37(11): 2154.     CrossRef
Prolonged QT Interval in Cirrhosis: Twisting Time?
William Lee, Bert Vandenberk, Satish R. Raj, Samuel S. Lee
Gut and Liver.2022; 16(6): 849.     CrossRef